Simon W.
- Country
- Denmark
- Department
- Department of Cardiology, Gødstrup Hospital
Research Overview
Data & Insights
Has run more than one trial at 0 of 1 partner site.
Specializations
Coronary Artery Disease and Acute Coronary Syndromes
The investigator focuses on the pathophysiology, risk stratification, and therapeutic optimization of coronary artery disease and related acute events.
- Acute myocardial infarction
- Non‑ST‑elevation myocardial infarction
- Unstable angina
- Secondary prevention after myocardial infarction
Research integrates cardiovascular imaging, biomarker profiling, and outcomes assessment to refine management strategies.
Heart Failure Across Ejection Fractions
Investigation of chronic and acute decompensation in heart failure with emphasis on preserved, mildly reduced, and reduced ejection fraction phenotypes.
- Heart failure with preserved ejection fraction (HFpEF)
- Heart failure with mildly reduced ejection fraction (HFmrEF)
- Heart failure with reduced ejection fraction (HFrEF)
- Volume overload management
Efforts include evaluation of neurohormonal modulation and fluid balance in high‑risk patients.
Cardiac Amyloidosis
The clinician explores infiltrative cardiomyopathies, particularly those driven by amyloid deposition.
- AL (light‑chain) amyloidosis
- Transthyretin amyloidosis (ATTR)
- Amyloid cardiomyopathy with heart failure
- Diagnostic imaging of amyloid burden
Work emphasizes early detection and disease‑specific therapeutic pathways.
Lipid Metabolism and Hypertriglyceridemia
Targeted research on dyslipidemic disorders that drive atherothrombosis, including elevated lipoprotein(a) and severe triglyceride elevations.
- Lipoprotein(a) reduction strategies
- Severe hypertriglyceridemia management
- Residual cardiovascular risk after statin therapy
- Genetic determinants of lipid disorders
Investigations aim to link lipid lowering with reduced major adverse cardiovascular events.
Renal‑Cardiac Interaction and Chronic Kidney Disease
Focused on the bidirectional impact of chronic kidney disease on cardiovascular outcomes and vice versa.
- CKD‑associated hypertension
- Diabetic kidney disease and cardiovascular risk
- Fluid overload in renal impairment
- Cardiorenal protective therapies
Research integrates renal function monitoring with cardiovascular event prevention.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.